PrimeRFP - AI-Powered RFP Solutions
PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26326F0016 — LENOLIDOMIDE CAPSULES

LENOLIDOMIDE CAPSULES is a federal award for Department of Veterans Affairs (VA) held by EXELAN PHARMACEUTICALS INC.. Estimated value $3.6M ($2.9M obligated). Current period of performance ends Sep 30, 2026. Last award drew 2 bidders. Place of performance: IOWA CITY IA.

$3.6M
Estimated Value
$2.9M
Obligated
Sep 30, 2026
PoP End / Expires
2
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

EXELAN PHARMACEUTICALS INC. holds $189.0M across 124 federal awards, concentrated at Department of Veterans Affairs (VA). Competition previously drew 2 offers. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number36C26326F0016
AgencyDepartment of Veterans Affairs (VA)
IncumbentEXELAN PHARMACEUTICALS INC.
CAGE6GFC4
UEIFYZXNHSQTMG8
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0227
Place of performanceIOWA CITY IA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startDec 1, 2025
PoP end (current)Sep 30, 2026
Obligated$2.9M
Current value$3.6M
Potential value$3.6M

Recompete timing

Public
● Expiring in 44 days

Current PoP ends Sep 30, 2026 (44 days remaining). Agencies typically plan 12–18 months ahead — at 1.4 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

EXELAN PHARMACEUTICALS INC. — $189.0M obligated across 124 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($189.0M) · all agencies
Department of Veterans Affairs (VA)$115.0M · 61%Department of Health and Human Services (HHS)$74.1M · 39%Department of Justice (DOJ)$17K · 0%
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 36C26326F0016
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open EXELAN PHARMACEUTICALS INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 36C26326F0016?

36C26326F0016 (LENOLIDOMIDE CAPSULES) is a Department of Veterans Affairs (VA) award with an estimated value of $3.6M, currently held by EXELAN PHARMACEUTICALS INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 36C26326F0016?

EXELAN PHARMACEUTICALS INC. is the incumbent with $189.0M across 124 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does 36C26326F0016 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79720D0227-36C26326F0016